Author

K. R. Vann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Acharya· 1 shared D. L. Durden· 1 shared G. A. Morales· 1 shared K. B. Challagundla· 1 shared K. Pandey· 1 shared M. Thurman· 1 shared S. N. Byrareddy· 1 shared T. G. Kutateladze· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Acharya

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Blockade of SARS-CoV-2 infection in-vitro by highly potent PI3K-α/mTOR/BRD4 inhibitor

A. Acharya, K. Pandey, M. Thurman, K. B. Challagundla, K. R. Vann, T. G. Kutateladze, G. A. Morales, D. L. Durden, S. N. Byrareddy

The paper demonstrates that SF2523, a PI3K-α/mTOR/BRD4 inhibitor, effectively blocks SARS-CoV-2 replication in vitro with an IC50 of 1.5 μM and shows synergy with remdesivir.

bioRxiv · Mar 2, 2021 · PreprintPharmacology & Toxicology